Patients with severe COVID-19 infections who have elevated factor V activity are at high risk for coagulopathy such as deep vein thrombosis and pulmonary embolism, US researchers have shown. Subsequent decreases in factor V were also linked to progression toward disseminated intravascular coagulation (DIC) and death, according to findings published in the American Journal of Hematology. ...
Factor V activity a key feature in COVID-19 outcomes
By Michael Woodhead
11 Sep 2020